Predictors of scaffold failure and impact of optimized scaffold implantation technique on outcome: Results from the German‐Austrian ABSORB RegIstRy
Open Access
- 18 June 2021
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 98 (4), E555-E563
- https://doi.org/10.1002/ccd.29829
Abstract
Aims We aimed to investigate predictors of scaffold failure and the potential impact of an optimized scaffold implantation technique by means of a learning curve on long-term clinical outcome after bioresorbable scaffold (BRS) implantation and to evaluate predictors of scaffold failure. Methods and results A total of 3326 patients were included in this prospective, observational, multi-center study (ClinicalTrials.gov NCT02066623) of consecutive patients undergoing BRS implantation between November 2013 and January 2016. The 3144 patients completed follow-up after 24 months, 3265 patients were eligible for time-to-event-analysis. Clinical endpoints were major adverse cardiac events–a composite endpoint of death, target vessel revascularization and myocardial infarction, and scaffold thrombosis (ScT). Patients were grouped according to treatment before or since 2015. During follow-up MACE rate improved from 2.52% after 30 days, 5.45% after 6 months and 12.67% after 24 months to 1.52%, 3.44%, and 10.52%, respectively. A total of 75 ScT occurred. In multiple regression analysis, treatment of bifurcations, long lesions, and procedures performed earlier than 2014 were identified as predictors for the occurrence of ScT. Conclusion Treatment of bifurcation lesions is the strongest predictor of ScT following BRS implantation. A significantly lower incidence of ScT and 24-month target lesion revascularization in patients recruited after 2014 into our observational registry suggests the influence of a learning curve.Keywords
This publication has 33 references indexed in Scilit:
- Meta-Analysis of Outcomes After Intravascular Ultrasound–Guided Versus Angiography-Guided Drug-Eluting Stent Implantation in 26,503 Patients Enrolled in Three Randomized Trials and 14 Observational StudiesThe American Journal of Cardiology, 2014
- Operator learning curve for transradial percutaneous coronary interventions: implications for the initiation of a transradial access program in contemporary US practiceCardiovascular Revascularization Medicine, 2014
- Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting StentsCirculation, 2014
- Expansion and malapposition characteristics after bioresorbable vascular scaffold implantationCatheterization and Cardiovascular Interventions, 2014
- A Next-Generation Bioresorbable Coronary Scaffold System: From Bench to First Clinical EvaluationJACC: Cardiovascular Interventions, 2014
- Looking into the future with bioresorbable vascular scaffoldsExpert Review of Cardiovascular Therapy, 2013
- Impact of the learning curve on outcomes after percutaneous mitral valve repair with MitraClip ® and lessons learned after the first 75 consecutive patientsEuropean Journal of Heart Failure, 2011
- From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?European Heart Journal, 2011
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound studyJournal of the American College of Cardiology, 2005